| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/05/2009 | EP1624884A4 Somatostatin vectors |
| 08/05/2009 | EP1531803A4 Method of inhibiting prostate cancer cell proliferation |
| 08/05/2009 | EP1512014B1 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 08/05/2009 | EP1499735B1 Optimization of transgene expression in mammalian cells |
| 08/05/2009 | EP1430085B1 Leukocyte inactivation module |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1286703B1 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 08/05/2009 | EP1282432B1 Use of peptide antagonists of zonulin for prevention or delay of the onset of diabetes |
| 08/05/2009 | EP1253939B1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 08/05/2009 | EP1235595B1 Integrin-mediated drug targeting |
| 08/05/2009 | EP1210115B1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 08/05/2009 | EP1142993B1 Method for detecting pancreatitis |
| 08/05/2009 | EP1087756B1 Particulate acellular tissue matrix |
| 08/05/2009 | EP1069907B1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
| 08/05/2009 | EP1029054B1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/05/2009 | EP0981614B1 Prostate cancer-specific marker |
| 08/05/2009 | EP0960935B1 Novel mouse cxc chemokine receptor |
| 08/05/2009 | CN101501696A Glycan data mining system |
| 08/05/2009 | CN101501501A Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma |
| 08/05/2009 | CN101501209A A method of producing biologically active polypeptide having insulinotropic activity |
| 08/05/2009 | CN101501067A Diuretic and natriuretic polypeptides |
| 08/05/2009 | CN101501065A VEGF analogs and methods of use |
| 08/05/2009 | CN101501064A Glycopeptide antibiotic derivative |
| 08/05/2009 | CN101501063A Polymyxin derivatives and uses thereof |
| 08/05/2009 | CN101501062A Novel biologically active peptides and their new uses |
| 08/05/2009 | CN101501061A Macrocyclic compounds as antiviral agents |
| 08/05/2009 | CN101501060A Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 08/05/2009 | CN101501058A Process for preparing particles of proteinaceous material |
| 08/05/2009 | CN101500605A Therapeutic methods for treating vascular eye disorders with Dll4 antagonists |
| 08/05/2009 | CN101500600A Methods for ester detoxication |
| 08/05/2009 | CN101500599A Dietary supplement formulations for improved delivery of coenzyme Q10 and methods of administration |
| 08/05/2009 | CN101500598A Cladribine regimen for treating multiple sclerosis |
| 08/05/2009 | CN101500597A Receptor antagonists for treatment of metastatic bone cancer |
| 08/05/2009 | CN101500596A Macrocyclic oximyl hepatitis c protease inhibitors |
| 08/05/2009 | CN101500595A 组合治疗 Combination therapy |
| 08/05/2009 | CN101500594A Methods and compositions for treating ophthalmic conditions via modulation of megalin activity |
| 08/05/2009 | CN101500593A Methods for regulating inflammatory mediators and peptides useful therein |
| 08/05/2009 | CN101500592A Compositions and methods for controlling tissue factor signaling specificity |
| 08/05/2009 | CN101500591A Compositions and methods using same for the detection of viruses |
| 08/05/2009 | CN101500590A Antibodies and related molecules that bind to 161P2F10B proteins |
| 08/05/2009 | CN101500589A Compositions and uses of a galectin for treatment of dry eye syndrome |
| 08/05/2009 | CN101500549A Casein complexes |
| 08/05/2009 | CN101500512A Methods and compositions for repair of cartilage using an in vivo bioreactor |
| 08/05/2009 | CN101497922A Use of PNMA5 gene |
| 08/05/2009 | CN101497887A Efficient and stable expression, purification and use of recombinant snake poison metal protease Jerdonitin |
| 08/05/2009 | CN101497886A Polypeptide of fungal thioredoxin, coding sequence, preparation and use |
| 08/05/2009 | CN101497881A Vaccine reading frame crosslinking with human molecule adjuvant hC3d3 same sense mutant |
| 08/05/2009 | CN101497878A Polypeptide of specific efficient affinity membrane type I substrate metal protease (MT1-MMP), protein and use |
| 08/05/2009 | CN101497671A Hydroxyalkyl starch derivatives |
| 08/05/2009 | CN101497666A Double specificity oligopeptide-cefuroxime sodium strengthened fusion protein Ec-LDP-Hr-AE |
| 08/05/2009 | CN101497661A Heaven dragon polypeptide derivative, as well as preparation and application thereof |
| 08/05/2009 | CN101497656A Polypeptide with high combination activity with integrin alpha v beta 3 and use thereof |
| 08/05/2009 | CN101497654A Melanocortin receptor agonists |
| 08/05/2009 | CN101497653A Small peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 08/05/2009 | CN101497652A Peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 08/05/2009 | CN101497651A Compound with thrombus dissolving activity, as well as preparation and use thereof |
| 08/05/2009 | CN101496827A Application of pumpkin protein in preparing medicament for treating chronic myeloid leukemia |
| 08/05/2009 | CN101496817A Application of clam active polypeptide in preparing anti-lung cancer medicament |
| 08/05/2009 | CN101496815A Medicament for treating hepatic failure and preparation method thereof |
| 08/05/2009 | CN101496773A Antimicrobial lotion containing wood frog antimicrobial peptide and preparation method thereof |
| 08/05/2009 | CN100523215C RNA interference mediating small RNA molecules |
| 08/05/2009 | CN100523213C Method for generating primate trophoblasts |
| 08/05/2009 | CN100523212C Process for producing tripeptides |
| 08/05/2009 | CN100523198C Method for detection of leptin receptor ligands |
| 08/05/2009 | CN100523189C Function and use of human immune cell inhibition acceptor KLRL1 |
| 08/05/2009 | CN100523188C Platlet glycoprotein IB alpha fusion polypeptides and methods of use thereof |
| 08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
| 08/05/2009 | CN100523185C Agkistrodonacutus thrombin preparation method and uses |
| 08/05/2009 | CN100523180C Recombinant malignant malarial parasite hypoxanthine-guanine-xanthine phosphoribosyl transferase and its preparing method and use |
| 08/05/2009 | CN100523172C Gene engineering bacteria of high efficiency expression of human alpha 1-thymulin and its construction method and use |
| 08/05/2009 | CN100522997C Method and composition for treating cardiovascular diseases by employing neuroregulation protein |
| 08/05/2009 | CN100522995C Cell wall acyl-alanyl-D-isoglutamine derivative and its preparation, medicine composition and use |
| 08/05/2009 | CN100522994C Discrimination between GnRH-I and GnRH-II |
| 08/05/2009 | CN100522993C Odorranagrahami antimicrobialpeptides and application thereof |
| 08/05/2009 | CN100522992C Novel ring-shape small-peptide BA and its use |
| 08/05/2009 | CN100522991C Peptidomimetic protease inhibitors |
| 08/05/2009 | CN100522988C Glycopegylation methods and proteins/peptides produced by the methods |
| 08/05/2009 | CN100522946C Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/05/2009 | CN100522249C Elogated and multiple spacers in activatible prodrugs |
| 08/05/2009 | CN100522245C Compositions for transmucosal drug delivery and cryoprotection |
| 08/05/2009 | CN100522244C High viscosity liquid controlled delivery system |
| 08/05/2009 | CN100522242C Artificial proteins with reduced immunogenicity |
| 08/05/2009 | CN100522241C Metal implant coated under reduced oxygen concentration with osteoinductive protein |
| 08/05/2009 | CN100522240C Medicinal composition for treating and improving brain function, its preparation method and application |
| 08/05/2009 | CN100522239C Pharmaceutical formulations for sustained drug delivery |
| 08/04/2009 | US7569711 Enone cancer therapeutics |
| 08/04/2009 | US7569683 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 08/04/2009 | US7569681 Caterpiller gene family |
| 08/04/2009 | US7569670 Cytokine zalpha11 ligand fusion proteins |
| 08/04/2009 | US7569669 For screening unknown compounds for antiinflammatory activity mediated by the arachidonic acid cascade |
| 08/04/2009 | US7569668 Method to control tumor progression and invasiveness |
| 08/04/2009 | US7569666 Polypeptides associated with activatory receptors and their biological applications |
| 08/04/2009 | US7569665 Comprises von willebrand factor a-related protein for use as diagnostic toll in diagnosis of autoimmune, arthritic and bone disorders |
| 08/04/2009 | US7569663 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases |
| 08/04/2009 | US7569662 Novel markers for lung cancer that are both sensitive and accurate; show a high degree of differential detection between lung cancer and non-cancerous states |
| 08/04/2009 | US7569661 Polypeptide scaffolds and use thereof |
| 08/04/2009 | US7569660 Recombinant prion-like proteins and materials comprising same |
| 08/04/2009 | US7569558 Chromium benfotiamine picolinate, copper adenosine triphosphate gluconate or vanadium pyridoxal-5-phosphate oxoglycinate; modulation of metalloenzymes; antiinflammatory, skin whitening, wrinkle reduction, skin aging control, cellular antioxidant, acne control, hair growth modulation |
| 08/04/2009 | US7569553 Dna bacteria; activate lymphocytes; nucleotide sequences; antigens; administering cytokines |
| 08/04/2009 | US7569548 Method of preparing peptide |